LFWD Lifeward Ltd. - Ordinary Shares
$7,59
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 14, 2026
Zakres 52 tyg.
$0–$10
78% of range
Ocena Analityków
BUY
8 analysts
Cena Docelowa
$20
+164% upside
P/E (TTM)
-0.4
ROE
-169.3%
Marża Zysku Netto
-90.4%
LFWD Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$7.58
Kapitalizacja Rynkowa
$12M
P/E (TTM)
-0.4
EPS (TTM)
$-17.16
Przychody (TTM)
$22M
Stopa dywidendy
—
ROE
-169.3%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$0 – $10
LFWD Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$22M
2016-12-31
→
2025-12-31
EPS
$-17.16
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-17M
2017-12-31
→
2025-12-31
Marże
-90.4%
2017-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
LFWD
Mediana porównawcza
P/E (TTM)
-0.4
—
P/S (TTM)
0.5
2.0
P/B
1.4
2.9
Price / FCF (Cena / FCF)
-0.7
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
LFWD
Mediana porównawcza
Gross Margin (Marża brutto)
38.2%
35.0%
Operating Margin (Marża Operacyjna)
-89.3%
—
Net Profit Margin (Marża Zysku Netto)
-90.4%
-297.9%
ROA
-74.6%
-108.3%
ROE
-169.3%
-227.4%
ROIC
-233.3%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
LFWD
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
1.3
2.4
Quick Ratio (Wskaźnik Szybkości)
0.7
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
LFWD
Mediana porównawcza
Revenue YoY (Przychody R/R)
-14.1%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
58.7%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
38.1%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
LFWD
Mediana porównawcza
LFWD Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
8 analityków
- Mocne kupno 2 25,0%
- Kup 5 62,5%
- Trzymaj 1 12,5%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
2 analityków · 2026-08-16
Mediana
$20.00
← Poniżej wszystkich celów
$7.58
Niski
$10.00
Wysoki
$30.00
Średni cel
$20.00
+163,7%
Średnia cel
$20.00
+163,7%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-1.4%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-1.46 | $-1.37 | -0.09% |
| 31 marca 2026 | $-3.13 | $-1.28 | -1.8% |
| 31 grudnia 2025 | $-3.60 | $-1.10 | -2.5% |
| 30 września 2025 | $-2.40 | $-2.63 | 0.23% |
| 30 czerwca 2025 | $-6.96 | $-3.73 | -3.2% |
| 31 marca 2025 | $-5.52 | $-4.65 | -0.87% |
| 31 grudnia 2024 | $-7.44 | $-6.28 | -1.2% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| LFWD | $879.6K | -0.0 | -14.1% | -90.4% | -169.3% | 38.2% |
| MBAI | — | — | — | — | — | — |
| ICCM | — | — | — | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22M | $26M | $14M | $6M | $6M | $4M | $5M | $7M | $8M | $6M | $4M | $4M | |
| Cost of Revenue | $14M | $17M | $9M | $4M | $3M | $2M | $2M | $4M | $5M | $5M | $4M | $4M | |
| Gross Profit | $8M | $8M | $4M | $2M | $3M | $2M | $3M | $3M | $3M | $736.0K | $214.0K | $-621.0K | |
| R&D Expense | $3M | $5M | $4M | $4M | $3M | $3M | $5M | $7M | $6M | $9M | $6M | $9M | |
| SG&A Expense | $8M | $5M | $10M | $7M | $6M | $5M | $5M | $7M | $8M | $8M | $6M | $3M | |
| Operating Expenses | $28M | $38M | $28M | $21M | $16M | $14M | $17M | $22M | $25M | $31M | $25M | $19M | |
| Operating Income | $-20M | $-29M | $-24M | $-19M | $-13M | $-12M | $-14M | $-19M | $-22M | $-30M | $-25M | $-20M | |
| Pretax Income | $-20M | $-29M | $-22M | $-19M | $-13M | $-13M | $-16M | $-22M | $-25M | $-32M | $-25M | $-22M | |
| Income Tax | $-55.0K | $43.0K | $-12.0K | $467.0K | $94.0K | $51.0K | $7.0K | $-5.0K | $119.0K | $3.0K | $53.0K | $45.0K | |
| Net Income | $-20M | $-29M | $-22M | $-20M | $-13M | $-13M | $-16M | $-22M | $-25M | $-33M | $-25M | $-22M | |
| EPS (Basic) | $-17.16 | $-39.96 | $-31.13 | $-2.20 | $-0.27 | $-0.82 | · | · | · | · | · | · | |
| EPS (Diluted) | $-17.16 | $-39.96 | $-31.13 | $-2.20 | $-0.27 | $-0.82 | · | · | · | · | · | · | |
| Shares (Basic) | 1,160,521 | 724,272 | 710,941 | 8,911,256 | 47,935,652 | 15,764,980 | · | · | · | · | · | · | |
| Shares (Diluted) | 1,160,521 | 724,272 | 710,941 | 8,911,256 | 47,935,652 | 15,764,980 | · | · | · | · | · | · | |
| EBITDA | $-20M | $-29M | · | · | · | $-12M | · | $-19M | $-21M | · | · | · |
Bilans 27
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $7M | $28M | $68M | $88M | $20M | $16M | $10M | $15M | $24M | $18M | $42M | |
| Receivables | $6M | $6M | $3M | $1M | $585.0K | $684.0K | $794.0K | $758.0K | $1M | $1M | $2M | $2M | |
| Inventory | $6M | $7M | $6M | $3M | $3M | $4M | $3M | $2M | $4M | $3M | $3M | $777.0K | |
| Prepaid Expense | $2M | $2M | $2M | $649.0K | $610.0K | $672.0K | $903.0K | $693.0K | $2M | $1M | $1M | $756.0K | |
| Other Current Assets | $393.0K | $289.0K | $747.0K | $152.0K | $63.0K | $33.0K | $164.0K | · | $458.0K | $671.0K | $512.0K | $89.0K | |
| Current Assets | $16M | $21M | $39M | $73M | $93M | $25M | $21M | $13M | $21M | $29M | $24M | $47M | |
| PP&E (Net) | $585.0K | $867.0K | $1M | $196.0K | $284.0K | $437.0K | $501.0K | $626.0K | $840.0K | $1M | $1M | $414.0K | |
| PP&E (Gross) | $8M | $8M | $8M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $749.0K | |
| Accum. Depreciation | $7M | $7M | $6M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $773.0K | $335.0K | |
| Goodwill | $5M | $8M | $8M | $0 | · | · | · | · | · | · | · | · | |
| Intangibles | · | $0 | $13M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $209.0K | $240.0K | $784.0K | $694.0K | $1M | $1M | $1M | $1M | $1M | · | · | · | |
| Total Assets | $23M | $30M | $63M | $74M | $95M | $28M | $24M | $15M | $23M | $32M | $26M | $48M | |
| Accounts Payable | $6M | $5M | $5M | $2M | $1M | $2M | $3M | $2M | $2M | $3M | $2M | $1M | |
| Current Liabilities | $12M | $10M | $12M | $5M | $4M | $5M | $10M | $5M | $10M | $12M | $4M | $4M | |
| Capital Leases | $1M | $22.0K | $607.0K | $333.0K | $418.0K | $923.0K | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $61.0K | $67.0K | $58.0K | $66.0K | $45.0K | $35.0K | $61.0K | $239.0K | $256.0K | $303.0K | $140.0K | $66.0K | |
| Total Liabilities | $14M | $12M | $17M | $6M | $5M | $6M | $14M | $13M | $19M | $24M | $5M | $4M | |
| Long-term Debt | · | · | · | · | · | · | $7M | $9M | $15M | $18M | $0 | · | |
| Total Debt | · | · | · | · | · | · | · | $9M | $15M | · | · | · | |
| Common Stock | $9M | $5M | $4M | $4M | $5M | $2M | $504.0K | $193.0K | $84.0K | $45.0K | $33.0K | $32.0K | |
| Paid-in Capital | $287M | $282M | $281M | $280M | $279M | $201M | $179M | $155M | $135M | $115M | $95M | $92M | |
| Retained Earnings | $-285M | $-265M | $-236M | $-214M | $-194M | $-181M | $-168M | $-153M | $-131M | $-106M | $-74M | $-49M | |
| Treasury Stock | $3M | $3M | $3M | $2M | $0 | · | · | · | · | · | · | · | |
| Stockholders' Equity | $8M | $19M | $47M | $68M | $89M | $22M | $11M | $2M | $4M | $8M | $21M | $44M | |
| Liabilities + Equity | $23M | $30M | $63M | $74M | $95M | $28M | $24M | $15M | $23M | $32M | $26M | $48M | |
| Shares Outstanding | 1,524,431 | 733,966 | 8,587,140 | 60,090,298 | 62,480,163 | 25,332,225 | 7,319,560 | 2,813,087 | 30,003,639 | 16,338,257 | 12,222,583 | 11,978,554 |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $642.0K | $696.0K | $438.0K | $111.0K | |
| Stock-based Comp | $743.0K | $1M | $1M | $993.0K | $833.0K | $749.0K | $1M | $3M | $4M | $3M | $2M | $5M | |
| Deferred Tax | · | $0 | $0 | $316.0K | $-29.0K | $-44.0K | $-57.0K | $-107.0K | $73.0K | $-5.0K | $-61.0K | $-60.0K | |
| Amort. of Intangibles | $0 | $3M | $2M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | $-2M | · | · | · | |
| Operating Cash Flow | $-17M | $-22M | $-21M | $-18M | $-11M | $-13M | $-15M | $-15M | $-22M | $-27M | $-25M | $-15M | |
| CapEx | $16.0K | $0 | $81.0K | $25.0K | $47.0K | $73.0K | $22.0K | $13.0K | $21.0K | $452.0K | $584.0K | $169.0K | |
| Investing Cash Flow | $-16.0K | $0 | $-18M | $-25.0K | $-47.0K | $-73.0K | $-22.0K | $-13.0K | $-21.0K | $-437.0K | · | · | |
| Debt Issued | · | · | · | $0 | $0 | $392.0K | · | · | · | $20M | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | $-7M | · | $-4M | $-3M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $1M | $9M | $4M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | $1M | $9M | · | · | · | |
| Financing Cash Flow | $12M | $0 | $-992.0K | $-2M | $80M | $17M | $21M | $10M | $13M | $34M | · | · | |
| Net Change in Cash | $-5M | $-22M | $-40M | $-20M | $68M | $4M | · | · | $-9M | $6M | $-24M | $33M | |
| Taxes Paid | $36.0K | $-7.0K | $126.0K | $113.0K | · | · | · | $2M | $2M | $1M | $163.0K | $0 | |
| Free Cash Flow | $-17M | $-22M | · | · | · | $-13M | · | $-15M | $-23M | · | · | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.2% | 32.0% | · | · | · | 49.8% | · | 43.2% | 40.0% | · | · | · | |
| Operating Margin | -89.3% | -114.4% | · | · | · | -273.2% | · | -293.6% | -283.7% | · | · | · | |
| Net Margin | -90.4% | -112.8% | · | · | · | -295.4% | · | -331.2% | -318.8% | · | · | · | |
| Pretax Margin | -90.6% | -112.6% | · | · | · | -294.2% | · | -331.2% | -317.3% | · | · | · | |
| EBITDA Margin | -89.3% | -114.4% | · | · | · | -273.2% | · | -293.6% | -275.4% | · | · | · | |
| ROA | -74.6% | -61.8% | · | · | · | -49.5% | · | -114.6% | -90.5% | · | · | · | |
| ROE | -169.3% | -109.7% | · | · | · | -67.3% | · | 1323.3% | -413.1% | · | · | · | |
| ROIC | -233.3% | -155.9% | · | · | · | -55.4% | · | -180.7% | -116.0% | · | · | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 2.1 | · | · | · | 5.4 | · | 2.5 | 2.2 | · | · | · | |
| Quick Ratio | 0.7 | 1.2 | · | · | · | 4.5 | · | 1.9 | 1.6 | · | · | · | |
| Debt / Equity | · | · | · | · | · | · | · | 4.5 | 4.1 | · | · | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | 3.6 | 2.4 | · | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.5 | · | · | · | 0.2 | · | 0.3 | 0.3 | · | · | · | |
| Inventory Turnover | 2.2 | 2.8 | · | · | · | 0.7 | · | 1.3 | 1.3 | · | · | · | |
| Receivables Turnover | 3.6 | 5.6 | · | · | · | 5.9 | · | 7.0 | 6.6 | · | · | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -14.1% | 85.2% | 151.4% | -7.6% | 35.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 58.7% | 62.6% | 46.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 38.1% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $22M | $26M | $14M | $6M | $6M | $4M | $5M | $7M | $8M | $6M | $4M | · | |
| Net Income TTM | $-20M | $-29M | $-22M | $-20M | $-13M | $-13M | $-16M | $-22M | $-25M | $-33M | $-25M | · | |
| Market Cap | $879.6K | $15M | · | · | · | $234M | · | $2.14B | $5.78B | · | · | · | |
| Enterprise Value | · | · | · | · | · | · | · | $2.14B | $5.78B | · | · | · | |
| P/E | -0.0 | -0.0 | -0.2 | -2.4 | -31.9 | -11.3 | · | · | · | · | · | · | |
| P/S | 0.0 | 0.6 | · | · | · | 53.3 | · | 327.2 | 745.0 | · | · | · | |
| P/B | 0.1 | 0.8 | · | · | · | 10.8 | · | 1101.0 | 1558.1 | · | · | · | |
| P / Tangible Book | 0.2 | 1.3 | 12.4 | 4.7 | 6.0 | 10.8 | · | · | · | · | · | · | |
| P / Cash Flow | -0.1 | -0.7 | · | · | · | -18.6 | · | -144.9 | -256.7 | · | · | · | |
| P / FCF | -0.1 | -0.7 | · | · | · | -18.5 | · | -144.8 | -256.5 | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | -111.4 | -270.6 | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | -144.8 | -256.5 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 327.1 | 745.1 | · | · | · | |
| Earnings Yield | -2974.0% | -2309.8% | -571.6% | -41.3% | -3.1% | -8.9% | · | · | · | · | · | · |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $4M | $5M | $6M | $6M | $5M | $8M | $6M | $7M | $5M | $7M | $4M | $1M | $1M | $2M | $886.0K | |
| Cost of Revenue | $4M | $3M | $4M | $3M | $3M | $3M | $6M | $4M | $4M | $4M | $4M | $4M | $761.0K | $659.0K | $2M | $665.0K | |
| Gross Profit | $3M | $1M | $1M | $3M | $3M | $2M | $2M | $2M | $3M | $1M | $2M | $863.0K | $576.0K | $571.0K | $673.0K | $221.0K | |
| R&D Expense | $2M | $6M | $843.0K | $721.0K | $767.0K | $918.0K | $1M | $998.0K | $1M | $1M | $1M | $1M | $816.0K | $752.0K | $1M | $1M | |
| SG&A Expense | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $240.0K | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $7M | $12M | $6M | $6M | $9M | $7M | $17M | $5M | $7M | $8M | $9M | $9M | $6M | $5M | $6M | $6M | |
| Operating Income | $-4M | $-10M | $-5M | $-3M | $-7M | $-5M | $-15M | $-3M | $-4M | $-7M | $-6M | $-8M | $-5M | $-4M | $-5M | $-5M | |
| Interest Expense | $7M | $416.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $394.0K | $557.0K | $73.0K | · | $0 | |
| Pretax Income | $-12M | $-11M | $-5M | $-3M | $-7M | $-5M | $-15M | $-3M | $-4M | $-6M | $-6M | $-8M | $-5M | $-4M | $-5M | $-5M | |
| Income Tax | $10.0K | $6.0K | $-73.0K | $7.0K | $0 | $11.0K | $3.0K | $29.0K | $5.0K | $6.0K | $-78.0K | $0 | $42.0K | $24.0K | $377.0K | $26.0K | |
| Net Income | $-12M | $-11M | $-5M | $-3M | $-7M | $-5M | $-15M | $-3M | $-4M | $-6M | $-6M | $-8M | $-5M | $-4M | $-5M | $-5M | |
| EPS (Basic) | $-4.12 | $-6.70 | $-15.92 | $-0.20 | $-7.01 | $-5.53 | $-38.38 | $-0.35 | $-0.50 | $-0.73 | $-29.19 | $-0.88 | $-0.55 | $-0.51 | $-1.97 | $-0.09 | |
| EPS (Diluted) | $-4.12 | $-6.70 | $-15.92 | $-0.20 | $-7.01 | $-5.53 | $-38.38 | $-0.35 | $-0.50 | $-0.73 | $-29.19 | $-0.88 | $-0.55 | $-0.51 | $-1.97 | $-0.09 | |
| Shares (Basic) | 2,796,621 | 1,610,969 | -36,576,468 | 16,021,411 | 935,785 | 873,845 | -25,231,635 | 8,756,882 | 8,608,937 | 8,590,088 | -24,836,107 | 8,542,630 | 8,502,201 | 8,502,217 | -178,920,554 | 62,793,847 | |
| Shares (Diluted) | 2,796,621 | 1,610,969 | -36,576,468 | 16,021,411 | 935,785 | 873,845 | -25,231,635 | 8,756,882 | 8,608,937 | 8,590,088 | -24,836,107 | 8,542,630 | 8,502,201 | 8,502,217 | -178,920,554 | 62,793,847 | |
| EBITDA | $-4M | $-10M | · | $-3M | $-7M | $-5M | · | $-3M | $-4M | $-7M | · | $-8M | $-5M | $-4M | · | $-5M |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $11M | $2M | $2M | $5M | $6M | $7M | $11M | $15M | $21M | · | $33M | $58M | $62M | · | $74M | |
| Receivables | $8M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $5M | $3M | · | $4M | $774.0K | $532.0K | · | $447.0K | |
| Inventory | $6M | $6M | $6M | $7M | $8M | $7M | $7M | $7M | $7M | $6M | · | $6M | $3M | $3M | · | $3M | |
| Prepaid Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $1M | · | $1M | |
| Other Current Assets | · | · | $393.0K | · | · | · | $289.0K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $26M | $26M | $16M | $17M | $21M | $20M | $21M | $26M | $30M | $33M | · | $44M | $64M | $67M | · | $79M | |
| PP&E (Net) | $527.0K | $571.0K | $585.0K | $641.0K | $730.0K | $777.0K | $867.0K | $1M | $1M | $1M | · | $1M | $129.0K | $160.0K | · | $237.0K | |
| PP&E (Gross) | · | · | $8M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $5M | $5M | $5M | $5M | $5M | $8M | $8M | $8M | $8M | $8M | · | $8M | · | · | · | · | |
| Intangibles | · | · | · | · | · | $0 | · | $10M | $11M | $12M | · | $13M | · | · | · | · | |
| Other Non-current Assets | $488.0K | $436.0K | $209.0K | $205.0K | $228.0K | $219.0K | $240.0K | $436.0K | $430.0K | $432.0K | · | $772.0K | $689.0K | $692.0K | · | $1M | |
| Total Assets | $35M | $33M | $23M | $23M | $27M | $29M | $30M | $46M | $51M | $55M | · | $69M | $66M | $69M | · | $81M | |
| Accounts Payable | $6M | $6M | $6M | $5M | $6M | $4M | $5M | $5M | $5M | $4M | · | $6M | $3M | $2M | · | $2M | |
| Current Liabilities | $11M | $11M | $12M | $9M | $10M | $9M | $10M | $10M | $10M | $10M | · | $13M | $5M | $4M | · | $4M | |
| Capital Leases | $2M | $1M | $1M | $88.0K | $79.0K | $48.0K | $22.0K | $45.0K | $123.0K | $354.0K | · | $856.0K | $541.0K | $657.0K | · | $85.0K | |
| Other Non-current Liabilities | $54.0K | $54.0K | $61.0K | $63.0K | $51.0K | $61.0K | $67.0K | $82.0K | $89.0K | $84.0K | · | $387.0K | $13.0K | $24.0K | · | $68.0K | |
| Total Liabilities | $23M | $27M | $14M | $10M | $12M | $10M | $12M | $12M | $14M | $15M | · | $17M | $7M | $5M | · | $5M | |
| Common Stock | $0 | $9M | $9M | $9M | $8M | $5M | $5M | $5M | $5M | $4M | · | $4M | $4M | $4M | · | $5M | |
| Paid-in Capital | $322M | $296M | $287M | $287M | $287M | $286M | $282M | $282M | $282M | $281M | · | $281M | $280M | $280M | · | $280M | |
| Retained Earnings | $-307M | $-296M | $-285M | $-279M | $-276M | $-270M | $-265M | $-250M | $-246M | $-242M | · | $-230M | $-223M | $-218M | · | $-208M | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $170.0K | |
| Stockholders' Equity | $12M | $6M | $8M | $13M | $15M | $18M | $19M | $34M | $37M | $41M | $47M | $52M | $59M | $64M | $68M | $76M | |
| Liabilities + Equity | $35M | $33M | $23M | $23M | $27M | $29M | $30M | $46M | $51M | $55M | · | $69M | $66M | $69M | · | $81M | |
| Shares Outstanding | 2,828,362 | 2,778,585 | 1,524,431 | 16,862,859 | 15,658,730 | 10,630,281 | 733,966 | 8,805,633 | 8,630,902 | 8,601,844 | · | 60,024,517 | 59,346,139 | 59,482,004 | · | 62,717,316 |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $262.0K | $177.0K | $167.0K | $174.0K | $182.0K | $220.0K | $234.0K | $290.0K | $376.0K | $381.0K | $373.0K | $333.0K | $318.0K | $304.0K | $347.0K | $320.0K | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $314.0K | $9.0K | |
| Amort. of Intangibles | $-5M | $5M | $0 | $0 | $0 | $0 | $842.0K | $842.0K | $832.0K | $831.0K | $844.0K | $764.0K | $0 | $0 | · | · | |
| Operating Cash Flow | $-6M | $-4M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M | $-6M | $-8M | $-4M | $-7M | $-4M | $-5M | $-4M | $-5M | |
| CapEx | $8.0K | $0 | $11.0K | $0 | $0 | $5.0K | $0 | $0 | $0 | $0 | $79.0K | $2.0K | $0 | $0 | $0 | $7.0K | |
| Investing Cash Flow | $-28.0K | $6M | $-11.0K | $0 | $0 | $-5.0K | $0 | $0 | $0 | $0 | $-79.0K | $-18M | $0 | $0 | $0 | $-7.0K | |
| Financing Cash Flow | $4M | $6M | $4M | $646.0K | $3M | $4M | $0 | $0 | $0 | $0 | $0 | $-6.0K | $-215.0K | $-771.0K | $-2M | $-183.0K | |
| Net Change in Cash | $-2M | $9M | $219.0K | $-3M | $-565.0K | $-1M | $-4M | $-4M | $-6M | $-8M | $-4M | $-26M | $-4M | $-6M | $-6M | $-5M | |
| Free Cash Flow | · | $-4M | · | · | · | $-5M | · | · | · | $-8M | · | · | · | $-5M | · | · | |
| Levered FCF | · | $-4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 40.9% | 34.2% | · | 43.7% | 43.9% | 42.1% | · | 36.2% | 41.1% | 26.4% | · | 19.6% | 43.1% | 46.4% | · | 24.9% | |
| Operating Margin | -62.7% | -263.6% | · | -50.7% | -114.7% | -96.4% | · | -51.8% | -66.2% | -123.1% | · | -180.4% | -385.8% | -355.7% | · | -613.2% | |
| Net Margin | -173.9% | -275.1% | · | -51.2% | -114.6% | -96.0% | · | -50.3% | -64.2% | -118.8% | · | -171.0% | -347.2% | -351.3% | · | -616.2% | |
| Pretax Margin | -173.8% | -275.0% | · | -51.1% | -114.6% | -95.8% | · | -49.9% | -64.1% | -118.7% | · | -171.0% | -344.1% | -349.4% | · | -613.3% | |
| EBITDA Margin | -62.7% | -263.6% | · | -50.7% | -114.7% | -96.4% | · | -51.8% | -66.2% | -123.1% | · | -180.4% | -385.8% | -355.7% | · | -613.2% | |
| ROA | -37.3% | -34.7% | · | -9.2% | -16.9% | -11.5% | · | -5.4% | -7.4% | -10.1% | · | -10.0% | -6.1% | -5.4% | · | -6.1% | |
| ROE | -84.3% | -87.2% | · | -13.6% | -25.3% | -16.4% | · | -7.2% | -9.0% | -12.0% | · | -11.8% | -6.6% | -5.8% | · | -6.5% | |
| ROIC | -34.0% | -164.4% | · | -24.7% | -43.4% | -26.4% | · | -9.4% | -12.1% | -16.0% | · | -15.3% | -8.8% | -6.9% | · | -7.2% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.4 | · | 1.9 | 2.0 | 2.2 | · | 2.7 | 3.0 | 3.2 | · | 3.5 | 11.7 | 17.2 | · | 18.7 | |
| Quick Ratio | 1.6 | 1.6 | · | 0.9 | 1.1 | 1.2 | · | 1.7 | 2.0 | 2.4 | · | 2.8 | 10.8 | 16.1 | · | 17.6 | |
| Interest Coverage | -0.6 | -24.9 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.6 | 0.4 | · | 0.5 | 0.4 | 0.5 | · | 0.6 | 0.8 | 0.9 | · | 0.8 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.0 | 0.7 | · | 1.0 | 1.0 | 1.2 | · | 1.3 | 2.2 | 2.6 | · | 2.2 | 1.6 | 2.2 | · | 1.0 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $22M | $21M | · | $23M | $24M | $23M | · | $23M | $18M | $12M | · | $8M | $5M | $5M | · | $5M | |
| Net Income TTM | $-32M | $-25M | · | $-18M | $-19M | $-18M | · | $-21M | $-23M | $-23M | · | $-22M | $-19M | $-19M | · | $-17M | |
| Market Cap | $22M | $18M | · | $12M | $10M | $18M | · | $29M | $35M | $45M | · | $319M | $249M | $300M | · | $390M | |
| P/E | -0.4 | -0.5 | · | -0.4 | -0.3 | -0.8 | · | -1.3 | -1.5 | -2.0 | · | -2.6 | -3.4 | -6.8 | · | -21.4 | |
| P/S | 1.0 | 0.9 | · | 0.5 | 0.4 | 0.8 | · | 1.3 | 2.0 | 3.7 | · | 40.6 | 49.6 | 65.7 | · | 73.5 | |
| P/B | 1.8 | 2.9 | · | 0.9 | 0.7 | 1.0 | · | 0.8 | 0.9 | 1.1 | · | 6.2 | 4.2 | 4.7 | · | 5.2 | |
| P / Tangible Book | 2.9 | 12.0 | · | 1.5 | 1.0 | 1.7 | · | 1.8 | 1.9 | 2.1 | · | 10.3 | 4.2 | 4.7 | · | 5.2 | |
| P / Cash Flow | · | -5.0 | · | · | · | -3.3 | · | · | · | -5.9 | · | · | · | -57.3 | · | · | |
| P / FCF | · | -5.0 | · | · | · | -3.3 | · | · | · | -5.9 | · | · | · | -57.3 | · | · | |
| Earnings Yield | -235.4% | -196.2% | · | -223.3% | -293.0% | -120.0% | · | -75.5% | -66.3% | -51.0% | · | -38.2% | -29.0% | -14.7% | · | -4.7% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $22M | $26M | $14M | $6M | $6M |
| Marża Brutto % | 38.2% | 32.0% | — | — | — |
| Marża Operacyjna % | -89.3% | -114.4% | — | — | — |
| Zysk netto | $-20M | $-29M | $-22M | $-20M | $-13M |
| Rozwodniony EPS | $-17.16 | $-39.96 | $-31.13 | $-2.20 | $-0.27 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 1.3 | 2.1 | — | — | — |
| Wskaźnik Szybkości | 0.7 | 1.2 | — | — | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-17M | $-22M | — | — | — |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 10 emitentów · $249K łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 2 | 1 | 1 | 2 | — |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary. Zmiana vs poprzedni kwartał nie pokazana: pokrycie zgłaszających różni się zbyt mocno między tymi dwoma kwartałami, aby można było dokonać wiarygodnego porównania.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | $141 802 | 18 064 | 56,97% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $86 765 | 11 327 | 34,86% | Akcje |
| UBS Group AG | $16 484 | 2 152 | 6,62% | Akcje |
| SBI Securities Co., Ltd. | $1 501 | 196 | 0,60% | Akcje |
| MORGAN STANLEY | $1 417 | 185 | 0,57% | Akcje |
| OSAIC HOLDINGS, INC. | $836 | 107 | 0,34% | Akcje |
| NATIONAL BANK OF CANADA /FI/ | $85 | 11 | 0,03% | Akcje |
| Caitong International Asset Management Co., Ltd | $31 | 4 | 0,01% | Akcje |
| ROYAL BANK OF CANADA | $0 | 50 | 0,00% | Akcje |
| Motiv8 Investments LLC | $0 | 41 | 0,00% | Akcje |
Insiderzy spółki 34 insiderów · 11 dyrektorzy generalni · 23 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| William Mark Grant | President & CEO | 25 marca 2026 A | — | 0 | 0 | $0 |
| Lawrence J Jasinski | Chief Executive Officer | 21 maja 2025 S | 98 728 | 0 | 0 | $0 |
| Almog Adar | Chief Financial Officer | 25 marca 2026 A | 262 500 | 0 | 0 | $0 |
| Michael A. Lawless | Chief Financial Officer | 23 maja 2024 P | 4 150 | 0 | 0 | $0 |
| Kevin Hershberger | Chief Financial Officer | 18 maja 2016 A | 15 400 | 0 | 0 | $0 |
| Keith Dale Rose | Chief Medical Officer | 1 maja 2026 A | 17 083 | 0 | 0 | $0 |
| Jeannine Lynch | VP of Market Access & Strategy | 11 grudnia 2025 A | 96 067 | 0 | 1 | $-1 018 |
| Charles Remsberg | Chief Sales Officer | 11 sierpnia 2023 A | 200 000 | 0 | 0 | $0 |
| Ofir Koren | Snr VP, R&D and Regulatory | 2 lipca 2020 A | 64 995 | 0 | 0 | $0 |
| John Vincent Hamilton | VP, Regulatory and Clinical | 25 lipca 2016 S | 5 665 | 0 | 0 | $0 |
| Jodi Gricci | VP Global Marketing & Training | 25 lipca 2016 S | 5 665 | 0 | 0 | $0 |
| William Mark Sigsbee | Dyrektor | 25 marca 2026 A | 11 485 | 0 | 0 | $0 |
| Moshe H Rozenbaum | Dyrektor | 25 marca 2026 A | 11 485 | 0 | 0 | $0 |
| Yehuda Reznick | Dyrektor | 25 marca 2026 A | 7 657 | 0 | 0 | $0 |
| Miriam Kidron | Dyrektor | 25 marca 2026 A | 7 657 | 0 | 0 | $0 |
| Nadav Kidron | Dyrektor | 25 marca 2026 A | 7 657 | 0 | 0 | $0 |
| Michael Swinford | Dyrektor | 1 sierpnia 2025 A | 45 960 | 0 | 0 | $0 |
| Hadar Levy | Dyrektor | 1 sierpnia 2025 A | 51 576 | 0 | 0 | $0 |
| Randel Richner | Dyrektor | 1 sierpnia 2025 A | 57 487 | 0 | 0 | $0 |
| Robert J. Marshall Jr. | Dyrektor | 1 sierpnia 2025 A | 35 920 | 0 | 0 | $0 |
| Joseph E Turk Jr | Dyrektor | 1 sierpnia 2025 A | 86 457 | 0 | 0 | $0 |
| John William Poduska SR | Dyrektor | 1 sierpnia 2025 A | 55 953 | 0 | 0 | $0 |
| Jeff Dykan | Dyrektor | 13 września 2023 A | 119 157 | 0 | 0 | $0 |
| Aryeh Dan | Dyrektor | 15 sierpnia 2023 S | 71 062 | 0 | 0 | $0 |
| Yohanan Engelhardt | Dyrektor | 2 sierpnia 2022 A | 80 585 | 0 | 0 | $0 |
| Yasushi Ichiki | Dyrektor | 2 sierpnia 2022 A | 80 645 | 0 | 0 | $0 |
| Wayne Weisman | Dyrektor | 2 sierpnia 2022 A | 50 000 | 0 | 0 | $0 |
| Chunlin Han | Dyrektor | 15 maja 2019 A | 11 029 | 0 | 0 | $0 |
| Ning Cong | Dyrektor | 27 marca 2019 A | 144 403 | 0 | 0 | $0 |
| Peter Wehrly | Dyrektor | 27 marca 2019 A | 139 223 | 0 | 0 | $0 |
| Deborah Disanzo | Dyrektor | 24 maja 2016 A | — | 0 | 0 | $0 |
| Glenn P Muir | Dyrektor | 24 maja 2016 A | — | 0 | 0 | $0 |
| Lind Global Fund II LP | Posiadacz 10% | 7 stycznia 2025 S | 857 996 | 0 | 0 | $0 |
| Ori Gon | — | 30 czerwca 2021 A | 241 282 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 3 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 14 maja 2026 | 49,90% | Pierwotne zgłoszenie | — | SEC |
| Lind Global Fund II LP, Lind Global Partners II LLC, Lind Global Macro Fund, LP, Lind Global Partners LLC, Jeff Easton ×3 zgłoszenia | 28 września 2023 | — | Pierwotne zgłoszenie | — | SEC |
| Timwell Corporation Limited (“Timwell”), Xu Han | 29 maja 2018 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.